High-Flow nasal cannula treatment in patients with COVID-19 acute hypoxemic respiratory failure: A prospective cohort study
Open Access
- 31 August 2021
- journal article
- research article
- Published by Medknow in Saudi Journal of Medicine & Medical Sciences
Abstract
Background: Early use of high‑flow nasal cannula (HFNC) decreases the need for endotracheal intubation (EI) in different respiratory failure causes. While HFNC is used in coronavirus disease 2019 (COVID‑19)‑related acute hypoxemic respiratory failure (AHRF) under weak recommendations, its efficacy remains to be investigated. Objectives: The primary objective was to examine HFNC efficacy in preventing EI among COVID‑19 patients with AHRF. Secondary objectives were to determine predictors of HFNC success/failure, mortality rate, and length of hospital and intensive care unit (ICU) stay. Patients and Methods: This is a prospective cohort study conducted at a single tertiary care centre in Saudi Arabia from April to August 2020. Adult patients admitted to the ICU with AHRF secondary to COVID‑19 pneumonia and managed with HFNC were included. We excluded patients who were intubated or managed with non‑invasive ventilation before HFNC. Results: Forty‑four patients received HFNC for a median duration of 3 days (interquartile range, 1–5 days). The mean age was 57 ± 14 years, and 86% were men. HFNC failure and EI occurred in 29 (66%) patients. Patients in whom HNFC treatment failed had a higher risk of death (52% versus 0%; P = 0.001). After adjusting for confounding factors, a high SOFA score and a low ROX index were significantly associated with HFNC failure (hazard ratio [HR], 1.42; 95% confidence interval [CI], 1.04–1.93; P = 0.025; and HR, 0.61; 95% CI, 0.42–0.88; P = 0.008, respectively). Conclusions: One‑third of hypoxemic COVID‑19 patients who received HFNC did not require intubation. High SOFA score and low ROX index were associated with HFNC failure.Keywords
This publication has 31 references indexed in Scilit:
- An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2019
- High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysisIntensive Care Medicine, 2019
- Exhaled air dispersion during high-flow nasal cannula therapyversusCPAPviadifferent masksEuropean Respiratory Journal, 2019
- Nasal high flow therapy: a novel treatment rather than a more expensive oxygen deviceEuropean Respiratory Review, 2017
- Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failureEuropean Respiratory Journal, 2017
- High flow nasal cannula versus conventional oxygen therapy and non-invasive ventilation in adults with acute hypoxemic respiratory failure: A systematic reviewRespiratory Medicine, 2016
- Randomized Controlled Trial of Humidified High-Flow Nasal Oxygen for Acute Respiratory Distress in the Emergency Department: The HOT-ER StudyRespiratory Care, 2015
- Heated Humidified High-Flow Nasal Oxygen in AdultsChest, 2015
- High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory FailureNew England Journal of Medicine, 2015
- High-flow nasal therapy in adults with severe acute respiratory infectionJournal of Critical Care, 2012